Evidence-based nutrition and diet, minus the fads. We look at what the research actually shows about eating patterns, supplements and popular diets — covering gut health, blood sugar, weight, and the role of food in preventing and managing chronic disease. Each article weighs the studies behind the headlines so you can separate genuine science from marketing, and make food choices grounded in evidence rather than hype.
6 articles
Which sugar substitutes actually help — and which quietly create new metabolic risks. A clear, practical guide to stevia, monk fruit, allulose, erythritol and artificial sweeteners, plus the label checks that stop hidden erythritol and other risky additives slipping into your diet.
Clear, evidence-first guide to GLP-1 weight loss drugs: what semaglutide and tirzepatide actually do, the trial results (15–20% average weight loss), what happens when you stop, real safety trade-offs, and the surprising early data on alcohol use — so you can discuss risks, cost, and longer-term strategy with your doctor.
Magnesium is essential but routinely missed: standard serum tests measure only ~1% of body stores, so normal bloodwork can hide true deficiency. This article explains why serum magnesium is misleading, the cardiovascular and muscle risks linked to low magnesium, who’s most vulnerable (including long-term PPI users and athletes), and practical, evidence-based steps to assess and protect your magnesium status.
Tea often feels calmer than coffee because it contains L-theanine. This article distils five human studies to show when L-theanine supports relaxation, how it works best with caffeine for a smoother 'calm focus', and what the evidence does — and doesn't — justify so you can choose between tea and…
Choline Benefits for Brain are often overlooked: only ~11% of adults meet recommended intake, yet choline fuels acetylcholine, liver fat transport and fetal brain growth. This article explains who needs more, which foods supply it, when to consider supplements and how to audit your own intake.
There's been a noticeable uptick in chronic cough reports among patients using GLP-1 receptor agonists, and it's not just the typical GI side effects we've been hearing about. This massive study - over 2 million patient records - found people with type 2 diabetes on these drugs had a 12% higher risk of a new chronic cough than those on other second-line diabetes medications…
